Dr. Robert W. Mays, Executive Vice President and Head of Regenerative Medicine & Neuroscience, will present live at the 2022 Cell & Gene Meeting on the Mesa in Carlsbad, California on October 11 at 4:00 pm PT. Dr. Mays will provide a corporate overview of the Company’s therapeutic MultiStem® cellular therapy, and an update on preclinical and clinical perspectives utilizing the MultiStem cellular platform technology to date. The presentation will provide an overview of the Company’s ongoing clinical studies in ischemic stroke, acute respiratory distress syndrome and trauma.
Mr. Dan Camardo, Chief Executive Officer, Ms. Maia Hansen, Chief Operating Officer, and Dr. Sarah Busch, Vice President of Regenerative Medicine, will also be in attendance from October 11-13 to meet with registered attendees.
A live video webcast of all company
presentations and sessions will be available for registered participants at http://www.meetingonthemesa.com and will also be published on the
conference website after the event concludes. In addition, a webcast of the
corporate presentation by Dr. Mays will be posted on the investor section of www.athersys.com when it becomes available. Please
visit www.meetingonthemesa.com for detailed conference information and
registration.